EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials
A US House committee has launched an investigation into drug trials conducted in China by major pharmaceutical companies, including Merck and AbbVie.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A US House committee has opened an investigation into pharmaceutical companies regarding drug trials conducted in China. According to coverage from Reuters and QZ, the probe specifically focuses on Merck and AbbVie, with QZ noting ties between these trials and the Chinese military.
Reporting from Endpoints News indicates that the House China panel is also questioning Bristol Myers and Pfizer concerning trial sites. Pharmaphorum adds that drugmakers are being asked to defend these operations.
Future developments will depend on the responses of the questioned companies and the findings of the House committee's investigation into the trial sites.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46m ago.
Quick answers
Which companies are being investigated?
Coverage identifies Merck and AbbVie as targets of the House committee investigation, while Endpoints News reports that Bristol Myers and Pfizer are also being questioned.
What is the primary concern regarding the trials?
According to QZ, the investigation involves drug trials in China that are tied to the Chinese military.
Which government body is conducting the probe?
The investigation is being led by a US House committee, specifically the House China panel.
Coverage (5)
- Pharmalittle: We're reading about Chinese trial sites being probed, RFK Jr. and peptides, and more statnews.com · 1h ago
- Drugmakers asked to defend Chinese trials; reports pharmaphorum · 1h ago
- Congress is investigating Merck and AbbVie over drug trials in China tied to its military qz.com · 1h ago
- Exclusive: House China panel questions Bristol Myers, Pfizer on trial sites Endpoints News · 1h ago
- EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials Reuters · 1h ago broke it first
People, places & organizations
Topics
Related trends
China's Xiaomi, Oppo, Vivo cut 2026 smartphone targets again: sources
Major Chinese smartphone manufacturers Xiaomi, Oppo, and Vivo are reducing their 2026 shipment targets amid rising costs and supply shortages.
China Loses Out on AI Boom as Stocks Trail by Most Since ‘01
Chinese stocks are trailing by their widest margin since 2001 as the nation struggles to capture the global AI boom.
China factory activity grows faster than expected in June on tech export demand
China's factory activity grew faster than expected in June, driven by strong demand for technology exports.
Lukashenko holds talks with Xi Jinping in China after meeting Putin
Belarusian President Lukashenko is strengthening ties with China and Russia amid simmering tensions with Ukraine.
Philippines leads the world in rush to solar as power prices soar
The Philippines has become the world's top buyer of solar panels as soaring electricity costs drive a massive shift toward rooftop energy.
Nvidia’s AI chip sales in China stall, as local chipmakers like Huawei take the lead
Nvidia faces stalling AI chip sales in China as local competitors like Huawei gain ground and banned hardware prices surge on the black market.